247 related articles for article (PubMed ID: 17376828)
1. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.
Tracy S; Drescher KM
Ann N Y Acad Sci; 2007 Apr; 1103():143-51. PubMed ID: 17376828
[TBL] [Abstract][Full Text] [Related]
2. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
[TBL] [Abstract][Full Text] [Related]
3. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
Tracy S; Drescher KM; Chapman NM; Kim KS; Carson SD; Pirruccello S; Lane PH; Romero JR; Leser JS
J Virol; 2002 Dec; 76(23):12097-111. PubMed ID: 12414951
[TBL] [Abstract][Full Text] [Related]
4. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.
Kanno T; Kim K; Kono K; Drescher KM; Chapman NM; Tracy S
J Virol; 2006 Jun; 80(11):5637-43. PubMed ID: 16699045
[TBL] [Abstract][Full Text] [Related]
5. Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice.
Davydova B; Härkönen T; Kaialainen S; Hovi T; Vaarala O; Roivainen M
J Med Virol; 2003 Apr; 69(4):510-20. PubMed ID: 12601759
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T-cells protect from type 1 diabetes after induction by coxsackievirus infection in the context of transforming growth factor-beta.
Richer MJ; Straka N; Fang D; Shanina I; Horwitz MS
Diabetes; 2008 May; 57(5):1302-11. PubMed ID: 18268045
[TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models.
Jaïdane H; Sané F; Gharbi J; Aouni M; Romond MB; Hober D
Diabetes Metab Res Rev; 2009 Oct; 25(7):591-603. PubMed ID: 19621354
[TBL] [Abstract][Full Text] [Related]
8. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
Sané F; Moumna I; Hober D
Expert Rev Clin Immunol; 2011 May; 7(3):357-66. PubMed ID: 21595602
[TBL] [Abstract][Full Text] [Related]
9. Requirements for viral-mediated autoimmune diabetes: beta-cell damage and immune infiltration.
Horwitz MS; Fine C; Ilic A; Sarvetnick N
J Autoimmun; 2001 May; 16(3):211-7. PubMed ID: 11334485
[TBL] [Abstract][Full Text] [Related]
10. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
11. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes.
Jaïdane H; Hober D
Diabetes Metab; 2008 Dec; 34(6 Pt 1):537-48. PubMed ID: 18951821
[TBL] [Abstract][Full Text] [Related]
12. Viral infections as potential triggers of type 1 diabetes.
van der Werf N; Kroese FG; Rozing J; Hillebrands JL
Diabetes Metab Res Rev; 2007 Mar; 23(3):169-83. PubMed ID: 17103489
[TBL] [Abstract][Full Text] [Related]
13. Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells.
Horwitz MS; Ilic A; Fine C; Balasa B; Sarvetnick N
Clin Immunol; 2004 Feb; 110(2):134-44. PubMed ID: 15003810
[TBL] [Abstract][Full Text] [Related]
14. Coxsackievirus can persist in murine pancreas by deletion of 5' terminal genomic sequences.
Tracy S; Smithee S; Alhazmi A; Chapman N
J Med Virol; 2015 Feb; 87(2):240-7. PubMed ID: 25111164
[TBL] [Abstract][Full Text] [Related]
15. Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes.
Elshebani A; Olsson A; Westman J; Tuvemo T; Korsgren O; Frisk G
Virus Res; 2007 Mar; 124(1-2):193-203. PubMed ID: 17169456
[TBL] [Abstract][Full Text] [Related]
16. Interferons induce an antiviral state in human pancreatic islet cells.
Hultcrantz M; Hühn MH; Wolf M; Olsson A; Jacobson S; Williams BR; Korsgren O; Flodström-Tullberg M
Virology; 2007 Oct; 367(1):92-101. PubMed ID: 17559902
[TBL] [Abstract][Full Text] [Related]
17. Coxsackieviruses and diabetes.
Ramsingh AI; Chapman N; Tracy S
Bioessays; 1997 Sep; 19(9):793-800. PubMed ID: 9297970
[TBL] [Abstract][Full Text] [Related]
18. Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes.
Richer MJ; Horwitz MS
Autoimmun Rev; 2009 Jun; 8(7):611-5. PubMed ID: 19393207
[TBL] [Abstract][Full Text] [Related]
19. Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect.
Stone VM; Butrym M; Hankaniemi MM; Sioofy-Khojine AB; Hytönen VP; Hyöty H; Flodström-Tullberg M
Diabetes; 2021 Dec; 70(12):2871-2878. PubMed ID: 34497136
[TBL] [Abstract][Full Text] [Related]
20. Maternal environment affects endogenous virus induction in the offspring of type 1 diabetes model non-obese diabetic mice.
Kagohashi Y; Udagawa J; Moriyama K; Otani H
Congenit Anom (Kyoto); 2005 Sep; 45(3):80-4. PubMed ID: 16131364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
